UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?
UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.
Time to Buy UnitedHealth-Heavy ETFs?
Berkshire's $1.57B stake in UnitedHealth lifted shares by 12%, sparking interest in UNH-heavy healthcare ETFs like IHF, TMED, XLV and MEDI.
UnitedHealth's Push Into Home Health: A New Growth Chapter?
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Why Is UnitedHealth Stock Trading Higher Friday? - UnitedHealth Group ( NYSE:UNH )
UNH stock up 10.57% after Buffett, Burry build positions Q2 EPS $4.08 misses $4.95 estimate; revenue at $111.62 billion. Get the latest proven ETF strategies to target and profit from summer volatility before the next big market swing. UnitedHealth Group Inc.
UnitedHealth Group Climbs 1.17% After Hours Following $2.21 Quarterly Dividend Authorization - Amedisys ( NASDAQ:AMED ) , UnitedHealth Group ( NYSE:UNH )
UnitedHealth Group Inc. UNH stock is trending on Thursday. UNH advanced 1.17% in after-hours trading to $275 on Wednesday, following the company's announcement of a $2.21 quarterly dividend authorization.
Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.
What's Going On With UnitedHealth Stock Monday? - UnitedHealth Group ( NYSE:UNH )
DOJ settlement forces sale of 164 facilities, cutting $528 million in annual revenue. Q2 EPS of $4.08 missed $4.95 estimate; revenue was also slightly below the consensus. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off → UnitedHealth Group Inc.
Why Is UnitedHealth Stock Trading Higher Today - Amedisys ( NASDAQ:AMED ) , UnitedHealth Group ( NYSE:UNH )
UnitedHealth to divest 164 facilities, impacting $528 million in revenue, to resolve merger concerns. Amedisys fined $1.1 million for inaccurate regulatory filings; must improve compliance training. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off →
Pennant ( PNTG ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Aug. 7, 2025, at 12 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Pennant Group ( PNTG ) Q2 Sales Up 30%
Pennant Group ( NASDAQ:PNTG ) , a diversified provider of home health, hospice, and senior living services, reported its second quarter 2025 earnings on August 6, 2025. The most notable news was the sharp revenue beat: GAAP total revenue of $219.5 million exceeded the analyst consensus of $210.62 ...
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth ( UNH ) Q2 2025 Earnings Transcript
Image source: The Motley Fool.Tuesday, July 29, 2025, at 8:45 a.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Amedisys ( AMED ) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Amedisys ( AMED ) Q2 Revenue Tops 5%
Amedisys ( NASDAQ:AMED ) , a leading provider of home health, hospice, and high acuity post-acute care services, reported quarterly earnings for the period ending June 30, 2025, on July 29, 2025. The most significant news is that the company outperformed market expectations on both revenue and ...
Amedisys ( AMED ) Beats Q2 Earnings and Revenue Estimates
Amedisys (AMED) delivered earnings and revenue surprises of +10.79% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Reports Second Quarter 2025 Financial Results
BATON ROUGE, La., July 29, 2025 ( GLOBE NEWSWIRE ) -- Amedisys, Inc. ( NASDAQ: AMED ) today reported its financial results for the three and six-month periods ended June 30, 2025.
Home Health Braces For Potential $1 Billion Cut In Medicare Payments - Addus HomeCare ( NASDAQ:ADUS )
CMS proposes a 6.4% drop in Medicare payments to home health agencies in 2026, totaling a $1.135 billion reduction. Amedisys earns 63% of revenue from home health; Addus sees 5%, with a focus on nonmedical care. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July ...
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
BTSG faces margin pressure, but strong first-quarter gains in Pharmacy Solution and Provider Services lift confidence.
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
BrightSpring Soars to All-Time High on Quality Strength: Still a Buy?
BTSG stock hits an all-time high with a 120% gain as soaring quality ratings and strong Q1 results fuel investor confidence.
BrightSpring's Care Ratings Climb: Is Its Lead Sustainable?
BTSG boosts care quality with tech upgrades, earning top ratings and patient satisfaction across all segments.
AMED or CHE: Which Is the Better Value Stock Right Now?
AMED vs. CHE: Which Stock Is the Better Value Option?
Are Medical Stocks Lagging Amedisys ( AMED ) This Year?
Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
UnitedHealth Spirals Downward Amid New Criminal Probe: Time to Sell?
UNH's troubles are piling up, from a fresh DOJ criminal probe and rising costs to leadership shakeups and pulled guidance.
Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?
Continued strength in revenue cycle operations is likely to have boosted DaVita's top line in the first quarter despite supply challenges weighing on its performance.
Home Healthcare Market size is projected to reach US$ 587.00 billion by 2031, at 8.5% CAGR - The Insight Partners
US & Canada, April 24, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global Home Healthcare Market is experiencing significant growth owing to the mounting prevalence of chronic diseases in the aging population and the cost-effectiveness of ...
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care.
Amedisys ( AMED ) Tops Q1 Earnings Estimates
Amedisys (AMED) delivered earnings and revenue surprises of 10.62% and 0%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Reports First Quarter 2025 Financial Results
BATON ROUGE, La., April 23, 2025 ( GLOBE NEWSWIRE ) -- Amedisys, Inc. ( NASDAQ: AMED ) today reported its financial results for the three-month period ended March 31, 2025.
Amedisys ( AMED ) Earnings Expected to Grow: Should You Buy?
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVAH Surges 45% in Five Days: How to Play the Stock After Earnings?
AVAH trades at a discount despite growth in payor deals & services. With solid fundamentals amid labor shortages, is it a buy or hold after earnings?
Here's Why You Should Retain AMED Stock in Your Portfolio Now
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
These Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in February 2025
While the current broad market sell-off dominates headlines, there's still value in looking at specific laggards from the major indexes. Among the blue-chip-laden Dow Jones Industrial Average ( DJINDICES: ^DJI ) , the two worst-performing stocks in the month of February were UnitedHealth Group ( ...
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.
Amedisys ( AMED ) Lags Q4 Earnings and Revenue Estimates
Amedisys (AMED) delivered earnings and revenue surprises of -8.57% and 0.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
BATON ROUGE, La., Feb. 26, 2025 ( GLOBE NEWSWIRE ) -- Amedisys, Inc. ( NASDAQ: AMED ) today reported its financial results for the three-month period and year ended December 31, 2024.
Why UnitedHealth Stock Is Down Today
The U.S. Department of Justice has reportedly launched an investigation into UnitedHealth Group's ( NYSE: UNH ) Medicare billing practices.Investors were shaken by the report, sending UnitedHealth shares down 9% as of 10 a.m.
UnitedHealth tumbles 12% on WSJ report the DOJ is investigating Medicare billing practices
The investigation centers on UnitedHealth's Medicare billing practices.
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.
Amedisys ( AMED ) Earnings Expected to Grow: Should You Buy?
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys Honors 47 Employees With Annual Spirit of Excellence Award
BATON ROUGE, La., Feb. 03, 2025 ( GLOBE NEWSWIRE ) -- Amedisys, Inc. ( NASDAQ: AMED ) , a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the prestigious Spirit of Excellence Awards, one of the company's highest honors.
Zehnder Communications Promotes Chassaignac to CEO
NASHVILLE, Tenn., Jan. 21, 2025 /PRNewswire/ -- Zehnder Communications, a fully integrated advertising agency with offices in Nashville, New Orleans, Baton Rouge and Rosemary Beach, has promoted Henry Chassaignac from president/executive creative director to chief executive officer.
UnitedHealth Group Q4 Earnings Preview: First Report Since Insurance CEO's Murder Comes With Questions On Company's Future - UnitedHealth Group ( NYSE:UNH )
UnitedHealth faces scrutiny over CEO's death, PBM practices, and DOJ blockage. Analysts watch for updates on guidance, growth, and post-Thompson leadership. Get Real-Time News and Alerts for Your Portfolio
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Amedisys ( NASDAQ:AMED ) , UnitedHealth Group ( NYSE:UNH )
UnitedHealth Group Incorporated UNH will release earnings results for its fourth quarter, before the opening bell on Thursday, Jan. 16, 2025. Analysts expect the Minnetonka, Minnesota-based company to report quarterly earnings at $6.75 per share, up from $6.16 per share in the year-ago period.
UnitedHealth's $3.3B Merger Stalls as VitalCaring Sale Falls Through
UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.
Company News for Dec 30, 2024
Companies In The News Are: AMED, UNH, LW, RGTI, COST.
Reasons to Retain AMED Stock in Your Portfolio Now
Amedisys' expected merger with UnitedHealth Group's Optum brings optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On? - Amedisys ( NASDAQ:AMED ) , UnitedHealth Group ( NYSE:UNH )
Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH. In an exchange filing, the companies entered into a waiver agreement, further advancing their merger deal, originally announced on June 26, ...
